Skip to main content
Top
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women

Authors: Bo T Hansen, Silje S Hukkelberg, Tor Haldorsen, Tormod Eriksen, Gry B Skare, Mari Nygård

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

Cervical cancer incidence and mortality may be reduced by organized screening. Participant compliance with the attendance recommendations of the screening program is necessary to achieve this. Knowledge about the predictors of compliance is needed in order to enhance screening attendance.

Methods

The Norwegian Co-ordinated Cervical Cancer Screening Program (NCCSP) registers all cervix cytology diagnoses in Norway and individually reminds women who have no registered smear for the past three years to make an appointment for screening. In the present study, a questionnaire on lifestyle and health was administered to a random sample of Norwegian women. The response rate was 68%. To address the predictors of screening attendance for the 12,058 women aged 25-45 who were eligible for this study, individual questionnaire data was linked to the cytology registry of the NCCSP. We distinguished between non-attendees, opportunistic attendees and reminded attendees to screening for a period of four years. Predictors of non-attendance versus attendance and reminded versus opportunistic attendance were established by multivariate logistic regression.

Results

Women who attended screening were more likely than non-attendees to report that they were aware of the recommended screening interval, a history of sexually transmitted infections and a history of hormonal contraceptive and condom use. Attendance was also positively associated with being married/cohabiting, being a non-smoker and giving birth. Women who attended after being reminded were more likely than opportunistic attendees to be aware of cervical cancer and the recommended screening interval, but less likely to report a history of sexually transmitted infections and hormonal contraceptive use. Moreover, the likelihood of reminded attendance increased with age. Educational level did not significantly affect the women's attendance status in the fully adjusted models.

Conclusions

The likelihood of attendance in an organized screening program was higher among women who were aware of cervical screening, which suggests a potential for a higher attendance rate through improving the public knowledge of screening. Further, the lower awareness among opportunistic than reminded attendees suggests that physicians may inform their patients better when smears are taken at the physician's initiative.
Literature
1.
go back to reference Bosch FX, de Sanjose S: Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr. 2003, 31: 3-13.CrossRefPubMed Bosch FX, de Sanjose S: Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr. 2003, 31: 3-13.CrossRefPubMed
2.
go back to reference IARC Working Group on the Evaluation of Cancer-Preventive Strategies: Cervix Cancer Screening. 2005, Lyon: IARC Press IARC Working Group on the Evaluation of Cancer-Preventive Strategies: Cervix Cancer Screening. 2005, Lyon: IARC Press
3.
go back to reference Laara E, Day NE, Hakama M: Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet. 1987, 1: 1247-1249.CrossRefPubMed Laara E, Day NE, Hakama M: Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet. 1987, 1: 1247-1249.CrossRefPubMed
4.
go back to reference Seidel D, Becker N, Rohrmann S, Nimptsch K, Linseisen J: Socio-demographic characteristics of participation in the opportunistic German cervical cancer screening programme: results from the EPIC-Heidelberg cohort. J Cancer Res Clin Oncol. 2009, 135: 533-541. 10.1007/s00432-008-0485-0.CrossRefPubMed Seidel D, Becker N, Rohrmann S, Nimptsch K, Linseisen J: Socio-demographic characteristics of participation in the opportunistic German cervical cancer screening programme: results from the EPIC-Heidelberg cohort. J Cancer Res Clin Oncol. 2009, 135: 533-541. 10.1007/s00432-008-0485-0.CrossRefPubMed
5.
go back to reference Ronco G, Segnan N, Ponti A: Who has Pap tests? Variables associated with the use of Pap tests in absence of screening programmes. Int J Epidemiol. 1991, 20: 349-353. 10.1093/ije/20.2.349.CrossRefPubMed Ronco G, Segnan N, Ponti A: Who has Pap tests? Variables associated with the use of Pap tests in absence of screening programmes. Int J Epidemiol. 1991, 20: 349-353. 10.1093/ije/20.2.349.CrossRefPubMed
6.
go back to reference Link BG, Northridge ME, Phelan JC, Ganz ML: Social epidemiology and the fundamental cause concept: on the structuring of effective cancer screens by socioeconomic status. Milbank Q. 1998, 76: 375-402. 10.1111/1468-0009.00096. 304-375CrossRefPubMedPubMedCentral Link BG, Northridge ME, Phelan JC, Ganz ML: Social epidemiology and the fundamental cause concept: on the structuring of effective cancer screens by socioeconomic status. Milbank Q. 1998, 76: 375-402. 10.1111/1468-0009.00096. 304-375CrossRefPubMedPubMedCentral
7.
go back to reference Maxwell CJ, Bancej CM, Snider J, Vik SA: Factors important in promoting cervical cancer screening among Canadian women: findings from the 1996-97 National Population Health Survey (NPHS). Can J Public Health. 2001, 92: 127-133.PubMed Maxwell CJ, Bancej CM, Snider J, Vik SA: Factors important in promoting cervical cancer screening among Canadian women: findings from the 1996-97 National Population Health Survey (NPHS). Can J Public Health. 2001, 92: 127-133.PubMed
8.
go back to reference Peters RK, Bear MB, Thomas D: Barriers to screening for cancer of the cervix. Prev Med. 1989, 18: 133-146. 10.1016/0091-7435(89)90059-5.CrossRefPubMed Peters RK, Bear MB, Thomas D: Barriers to screening for cancer of the cervix. Prev Med. 1989, 18: 133-146. 10.1016/0091-7435(89)90059-5.CrossRefPubMed
9.
go back to reference Webb R, Richardson J, Esmail A, Pickles A: Uptake for cervical screening by ethnicity and place-of-birth: a population-based cross-sectional study. J Public Health. 2004, 26: 293-296. 10.1093/pubmed/fdh128.CrossRef Webb R, Richardson J, Esmail A, Pickles A: Uptake for cervical screening by ethnicity and place-of-birth: a population-based cross-sectional study. J Public Health. 2004, 26: 293-296. 10.1093/pubmed/fdh128.CrossRef
10.
go back to reference Oscarsson MG, Benzein EG, Wijma BE: Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden. J Psychosom Obstet Gynaecol. 2008, 29: 23-31. 10.1080/01674820701504619.CrossRefPubMed Oscarsson MG, Benzein EG, Wijma BE: Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden. J Psychosom Obstet Gynaecol. 2008, 29: 23-31. 10.1080/01674820701504619.CrossRefPubMed
11.
go back to reference Eaker S, Adami HO, Sparen P: Reasons women do not attend screening for cervical cancer: A population-based study in Sweden. Prev Med. 2001, 32: 482-491. 10.1006/pmed.2001.0844.CrossRefPubMed Eaker S, Adami HO, Sparen P: Reasons women do not attend screening for cervical cancer: A population-based study in Sweden. Prev Med. 2001, 32: 482-491. 10.1006/pmed.2001.0844.CrossRefPubMed
12.
go back to reference Kjær SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, Liaw KL, Nygård J, Nygård M: The burden of genital warts: A study of nearly 70.000 women from the general female population in the 4 Nordic countries. J Infect Dis. 2007, 196: 1447-1454. 10.1086/522863.CrossRefPubMed Kjær SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, Liaw KL, Nygård J, Nygård M: The burden of genital warts: A study of nearly 70.000 women from the general female population in the 4 Nordic countries. J Infect Dis. 2007, 196: 1447-1454. 10.1086/522863.CrossRefPubMed
13.
go back to reference Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T: Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008, 337: a1754-10.1136/bmj.a1754.CrossRefPubMedPubMedCentral Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T: Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008, 337: a1754-10.1136/bmj.a1754.CrossRefPubMedPubMedCentral
14.
go back to reference Appleby P, Beral V, Gonzalez AB, Colin D, Franceschi S, Goodill A, Green J, Peto J, Plummer M, Sweetland S, La Vecchia C, Bosch FX, Hererro R, Hildesheim A, Skegg D, Thomas D, Rajkumar T, Cuzick J, Bull D, Crossley B, Green J, Reeves G, Kjaer S, Painter R, Vessey M, Daling J, Madeleine M, Ray R, Ylitalo N, Castellsague X, et al: Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies - International collaboration of epidemiological studies of cervical cancer. Int J Cancer. 2006, 118: 1481-1495.CrossRefPubMed Appleby P, Beral V, Gonzalez AB, Colin D, Franceschi S, Goodill A, Green J, Peto J, Plummer M, Sweetland S, La Vecchia C, Bosch FX, Hererro R, Hildesheim A, Skegg D, Thomas D, Rajkumar T, Cuzick J, Bull D, Crossley B, Green J, Reeves G, Kjaer S, Painter R, Vessey M, Daling J, Madeleine M, Ray R, Ylitalo N, Castellsague X, et al: Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies - International collaboration of epidemiological studies of cervical cancer. Int J Cancer. 2006, 118: 1481-1495.CrossRefPubMed
15.
go back to reference Orbell S, Crombie I, Robertson A, Johnston G, Kenicer M: Assessing the effectiveness of a screening campaign: who is missed by 80% cervical screening coverage?. J R Soc Med. 1995, 88: 389-394.PubMedPubMedCentral Orbell S, Crombie I, Robertson A, Johnston G, Kenicer M: Assessing the effectiveness of a screening campaign: who is missed by 80% cervical screening coverage?. J R Soc Med. 1995, 88: 389-394.PubMedPubMedCentral
16.
go back to reference Manhart LE, Koutsky LA: Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia?. Sex Transm Dis. 2002, 29: 725-735. 10.1097/00007435-200211000-00018.CrossRefPubMed Manhart LE, Koutsky LA: Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia?. Sex Transm Dis. 2002, 29: 725-735. 10.1097/00007435-200211000-00018.CrossRefPubMed
17.
go back to reference Nygard M, Daltveit AK, Thoresen SO, Nygard JF: Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study. BMC Health Serv Res. 2007, 7: 10-10.1186/1472-6963-7-10.CrossRefPubMedPubMedCentral Nygard M, Daltveit AK, Thoresen SO, Nygard JF: Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study. BMC Health Serv Res. 2007, 7: 10-10.1186/1472-6963-7-10.CrossRefPubMedPubMedCentral
18.
go back to reference Parikh S, Brennan P, Boffetta P: Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003, 105: 687-691. 10.1002/ijc.11141.CrossRefPubMed Parikh S, Brennan P, Boffetta P: Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003, 105: 687-691. 10.1002/ijc.11141.CrossRefPubMed
19.
go back to reference Franceschi S, Plummer M, Clifford G, de Sanjose S, Bosch X, Herrero R, Munoz N, Vaccarella S: Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer. 2009, 101: 865-870. 10.1038/sj.bjc.6605224.CrossRefPubMedPubMedCentral Franceschi S, Plummer M, Clifford G, de Sanjose S, Bosch X, Herrero R, Munoz N, Vaccarella S: Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer. 2009, 101: 865-870. 10.1038/sj.bjc.6605224.CrossRefPubMedPubMedCentral
20.
go back to reference Pukkala E, Malila N, Hakama M: Socioeconomic differences in incidence of cervical cancer in Finland by cell type. Acta Oncol. 2010, 49: 180-184. 10.3109/02841860903386390.CrossRefPubMed Pukkala E, Malila N, Hakama M: Socioeconomic differences in incidence of cervical cancer in Finland by cell type. Acta Oncol. 2010, 49: 180-184. 10.3109/02841860903386390.CrossRefPubMed
21.
go back to reference Segnan N: Socioeconomic status and cancer screening. Social Inequalities and Cancer. Edited by: Kogevinas M, Pearce N, Susser M, Boffetta P. 1997, Lyon: IARC, 369-376. Segnan N: Socioeconomic status and cancer screening. Social Inequalities and Cancer. Edited by: Kogevinas M, Pearce N, Susser M, Boffetta P. 1997, Lyon: IARC, 369-376.
22.
go back to reference Sarkadi A, Widmark C, Tornberg S, Tishelman C: The 'hows', 'whos', and 'whens' of screening: gynaecologists' perspectives on cervical cancer screening in urban Sweden. Soc Sci Med. 2004, 58: 1097-1108. 10.1016/S0277-9536(03)00280-6.CrossRefPubMed Sarkadi A, Widmark C, Tornberg S, Tishelman C: The 'hows', 'whos', and 'whens' of screening: gynaecologists' perspectives on cervical cancer screening in urban Sweden. Soc Sci Med. 2004, 58: 1097-1108. 10.1016/S0277-9536(03)00280-6.CrossRefPubMed
23.
go back to reference Moser K, Patnick J, Beral V: Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ. 2009, 338: b2025-10.1136/bmj.b2025.CrossRefPubMedPubMedCentral Moser K, Patnick J, Beral V: Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ. 2009, 338: b2025-10.1136/bmj.b2025.CrossRefPubMedPubMedCentral
24.
go back to reference Rodvall Y, Kemetli L, Tishelman C, Tornberg S: Factors related to participation in a cervical cancer screening programme in urban Sweden. Eur J Cancer Prev. 2005, 14: 459-466. 10.1097/01.cej.0000178078.21910.da.CrossRefPubMed Rodvall Y, Kemetli L, Tishelman C, Tornberg S: Factors related to participation in a cervical cancer screening programme in urban Sweden. Eur J Cancer Prev. 2005, 14: 459-466. 10.1097/01.cej.0000178078.21910.da.CrossRefPubMed
25.
go back to reference Lancucki L, Fender M, Koukari A, Lynge E, Mai V, Mancini E, Onysko J, Ronco G, Tornberg S, Vessey M, Patnick J: A fall-off in cervical screening coverage of younger women in developed countries. J Med Screen. 2010, 17: 91-96. 10.1258/jms.2010.010017.CrossRefPubMed Lancucki L, Fender M, Koukari A, Lynge E, Mai V, Mancini E, Onysko J, Ronco G, Tornberg S, Vessey M, Patnick J: A fall-off in cervical screening coverage of younger women in developed countries. J Med Screen. 2010, 17: 91-96. 10.1258/jms.2010.010017.CrossRefPubMed
26.
go back to reference Waller J, Bartoszek M, Marlow L, Wardle J: Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2009, 16: 199-204. 10.1258/jms.2009.009073.CrossRefPubMed Waller J, Bartoszek M, Marlow L, Wardle J: Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2009, 16: 199-204. 10.1258/jms.2009.009073.CrossRefPubMed
27.
go back to reference Bowman JA, Sanson-Fisher R, Redman S: The accuracy of self-reported Pap smear utilisation. Soc Sci Med. 1997, 44: 969-976. 10.1016/S0277-9536(96)00222-5.CrossRefPubMed Bowman JA, Sanson-Fisher R, Redman S: The accuracy of self-reported Pap smear utilisation. Soc Sci Med. 1997, 44: 969-976. 10.1016/S0277-9536(96)00222-5.CrossRefPubMed
28.
go back to reference Klungsoyr O, Nygard M, Skare G, Eriksen T, Nygard JF: Validity of self-reported Pap smear history in Norwegian women. J Med Screen. 2009, 16: 91-97. 10.1258/jms.2009.008087.CrossRefPubMed Klungsoyr O, Nygard M, Skare G, Eriksen T, Nygard JF: Validity of self-reported Pap smear history in Norwegian women. J Med Screen. 2009, 16: 91-97. 10.1258/jms.2009.008087.CrossRefPubMed
Metadata
Title
Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women
Authors
Bo T Hansen
Silje S Hukkelberg
Tor Haldorsen
Tormod Eriksen
Gry B Skare
Mari Nygård
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-264

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue